Nick Gallo's profile photo

Nick Gallo

Oklahoma City

Sideline Reporter and Digital Editor at Oklahoma City Thunder

Sideline Reporter and Digital Editor at Bally Sports

Sideline Reporter & Digital Editor for @okcthunder and @FanDuelSN. Formerly @nyjets and @titans. @VanderbiltU grad. Durham, NC raised.

Articles

  • 1 week ago | investopedia.com | Nick Gallo

    Located 220 miles east of Seattle, the town of Omak, Washington is a hidden gem nestled in the curve of the Okanogan River and surrounded by national forests. With just over 5,000 residents, it's the largest city in a small county of about 43,000 people, offering a quiet, close-knit community to match its scenic surroundings.

  • 1 month ago | thesportingtribune.com | Nick Gallo

    LOS ANGELES -- A bit of a landmark episode here to have on our first NHL'er guest and a guy I watched coming up in Junior as a smooth skating shutdown defenseman before becomin

  • Oct 31, 2024 | wsj.com | Nick Gallo

    TD Bank at a glanceTD Bank Group was established in 1955 through the merger of the Bank of Toronto and the Dominion Bank. Today, it serves over 27.5 million customers globally, offering a wide range of financial products and services. Its subsidiary, TD Bank, provides personal loans in the U.S, primarily in states along the East Coast. Annual percentage rate (APR)9.99% - 23.99%Loan amount$2,000 - $50,000Term length3 - 5 yearsMin.

  • Oct 1, 2024 | microbiometimes.com | Nick Gallo

    Florey Biosciences, a synthetic biology company spun out of the Wyss Institute for Biologically Inspired Engineering at Harvard University, today announced that it has secured pre-seed funding and is unveiling its lead program, a probiotic medical food designed for the management of antibiotic damage to the gut microbiome. While often essential and sometimes life-saving, antibiotics can disrupt the beneficial microbes in the gut, collectively known as the microbiome.

  • Sep 23, 2024 | microbiometimes.com | Nick Gallo

    GN Corporation’s Neu REFIX Beta glucan, made in Japan has received both Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (US FDA) for treatment of Duchenne muscular Dystrophy (DMD). These designations would help take the progress in pre-clinical and clinical studies conducted in Japan and India to clinical trials in the USA, for approval by FDA.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
11K
Tweets
9K
DMs Open
Yes
Nick Gallo
Nick Gallo @NickAGallo
10 Apr 25

RT @okcthunder: See ya in Salt Lake, Thunder Nation 😴 https://t.co/4zCSqgmHkG

Nick Gallo
Nick Gallo @NickAGallo
10 Apr 25

Jalen Williams postgame: That’s what makes our team so special, is we just relish in the fact that a next man up mentality is how we play. So everybody looks at it as their way to shine, but I think we also do a really good job of playing within each other and playing as a team

Nick Gallo
Nick Gallo @NickAGallo
10 Apr 25

RT @okcthunder: Always trusting one another 🤝 @jdubwttp checks in with @NickAGallo postgame 🎤 https://t.co/t8gvKS7Mdh